100 Questions & Answers About Myelodysplastic Syndromes
Empower Yourself! MDS is a lethal blood disease that affects as many as 50 per 100,000 individuals over the age of 70. The disorder is five times more prevalent than AML, a form of leukemia. Whether you're a newly diagnosed patient, a survivor, or loved one of someone suffering from MDS, this book offers help. The only text available to provide both the doctor's and patient's views, 100 Questions & Answers About Myelodysplastic Syndromes, provides practical, authoritative answers to 100 of the most common questions asked. Written with commentary from actual patients, this is an invaluable resource for anyone struggling with the medical, physical, and emotional turmoil of this disease.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
5-azacitidine and decitabine acute myelogenous leukemia antibiotics bleeding blood cell count blood cell growth blood cell response blood cell transfusions bone marrow biopsy cell growth factor chemotherapy chromosome abnormalities classification clinical trial clotting CMML complete blood count decitabine decreased deferasirox develop diagnosis of MDS disease disorder doctor dose drug dysplasia evaluate fibrosis function G-CSF g/dL genes growth factor injections GVHD hematologist hemoglobin higher-risk MDS hospital improve increased intermediate-2 IPSS iron overload lenalidomide liver low blood counts low platelet count lower-risk marrow blasts MDS patients myelodysplastic syndromes needle neutropenia neutrophil neutrophil count normal occur patients with MDS phase Phone physician platelet transfusions potential prognosis RARS red blood cell referred Refractory anemia ringed sideroblasts risk Scoring System side effects stem cell transplantation subtype of MDS supportive symptoms therapy thrombocytopenia tion tissue treat usually white blood cell